Mitos e verdades sobre o uso de antiplaquetários na intervenção percutânea

By Dr. Roberto Esporcatte.

roberto esporcatte

More articles by this author

Venus P-Valve: The valve and initial clinical worldwide experience

Por Dr. Alejandro Peirone.

FFR EM LESÕES SEQUENCIAIS E DOENÇA DIFUSA

Por Dr. Silvio Gioppato.  

Erros mais comuns na realização do FFR: como identificá-los e preveni-los

Por Dr. Fernando Mendes Sant’Anna.  

Análise Crítica do Estudo Leaders É o melhor stent que temos?

Por Dr. Esmeralci Ferreira.  

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...